Special Issue "Medicinal Plants and Natural Compounds for Potential Use in Aging-Related Disorders"
Deadline for manuscript submissions: closed (30 September 2023) | Viewed by 8006
2. International Center for Biomedicine-ICC, Santiago, Chile
Interests: Alzheimer; tau protein; neuroimmunomodulation theory; disease prevention; nutraceutical compounds; multi target compounds; non-pharmacological treatment
Aging is a progressive physiological change in an organism that leads to senescence or a decline in biological functioning. Occasionally, this is manifested by its close association with an increased incidence of human diseases and higher vulnerability to death. Currently, diseases such as diabetes, cancer, and cardiovascular and neurodegenerative disorders have been related to aging, without successful treatment. However, natural products have been shown to prevent or delay the onset of those aging-associated diseases through various action mechanisms. Natural products, and many nutraceuticals, have played essential roles in aging research due to their chemical structure diversity and the rich obtaining sources documented in different countries or cultures. We aim to develop a Special Issue for Pharmaceuticals that identifies the molecular pathways underlying novel natural products in aging, and establishes their biotechnological uses as anti-aging treatments, and eventually provide a solution to aging-associated diseases.
Prof. Dr. RICARDO B. MACCIONI
Dr. Camila Calfio
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- bioactive molecules
- mechanisms of action
- non-pharmacological therapies
- disease prevention
- human aging
- natural products-based formulations